Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million)
01/25/21, 8:04 AM
Location
Money raised
£12 million
Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing.